Drug Type Small molecule drug |
Synonyms KY1022 |
Target |
Action inhibitors |
Mechanism CTNNB inhibitors(Beta catenins inhibitors), RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H19N3OS |
InChIKeyINRQXFWQQLFWNZ-UHFFFAOYSA-N |
CAS Registry1029721-36-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | South Korea | 07 Nov 2016 |